Ask the Expert: What Role Do Risk Stratification Tools Play in Focal Therapy?
Thomas J. Polascik, MD, Duke University, Durham, North Carolina, discusses the role risk...
Read MoreSelect Page
Thomas J. Polascik, MD, FACS, is Professor of Surgery at Duke University Medical Center and the Director of Surgical Technology at the Duke Prostate and Urological Cancer Center. He is the Founder and Co-Director of the International Symposium on Focal Therapy and Imaging of Prostate and Kidney Cancer, which began at Duke in 2008. Dr. Polascik is the Editor of Imaging and Focal Therapy of Early Prostate Cancer. He is Founder and President of the Focal Therapy Society, as well as Director of Duke’s Society of Urologic Oncology Fellowship Training Program and the Genitourinary Program on Focal Therapy at the Duke Cancer Institute. He is the Medical Director of Duke’s Men’s Health Initiative Screening Event and is a governing member of several medical boards and societies. His clinical and research interests focus on prostate and kidney cancer. He has authored over 350 peer-reviewed manuscripts and book chapters.
Disclosures:Posted by Thomas J. Polascik, MD, FACS | Oct 2017
Thomas J. Polascik, MD, Duke University, Durham, North Carolina, discusses the role risk...
Read MorePosted by Thomas J. Polascik, MD, FACS | Mar 2017
Dr. Thomas J. Polascik presented “Current Findings on High Intensity Focused Ultrasound...
Read MorePosted by Thomas J. Polascik, MD, FACS | Mar 2017
Dr. Thomas J. Polascik presented “New Horizons in Focal Therapy” at the 27th annual...
Read MorePosted by Thomas J. Polascik, MD, FACS | Mar 2017
Dr. Thomas J. Polascik presented “Highlights from the 9th International Symposium on Focal...
Read More